VEGFA and myopic macular degeneration: These modalities enable precise imaging of the retina, choroid, and sclera, allowing for the identification of structural abnormalities, progression of degenerative changes, and detection of complications like retinal detachment or myopic maculopathy, while therapeutic options, including vascular endothelial growth factor (anti-VEGF) therapy, vitrectomy, and scleral reinforcement, offer potential avenues for stabilizing or improving visual outcomes.